In conclusion, we identify a strong prognostic impact of neuroendocrine-lineage transcriptional profiles in neuroblastoma, and suggest that the evaluation of NOTCH1, INSM1, YAP1, and NEUROD1 might help to further characterize the risk of relapse in neuroblastoma patients. This evidence concerns the gene NOTCH1 and neuroblastoma.